Reporter Oct 3 2014

aspirin pills
October 2, 2014

Low-dose aspirin’s protective effect in cancer explained

For years, scientists have known that regular aspirin use may reduce the risk of cancer.

By VUMC News and Communications
HIV cell
October 2, 2014

Traditional healers contribute to HIV care delays: study

If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer.

By Paul Govern
Cholesterol
October 2, 2014

Team spots key regulator for cholesterol production

A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223.

By Bill Snyder
October 2, 2014

VUSM’s history of diversity efforts commemorated

It has been nearly 50 years since the first black student entered Vanderbilt University School of Medicine (VUSM), and Vanderbilt has come a long way since then.

By Jessica Pasley
October 2, 2014

Program focuses on heart health of cancer patients

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.

By Kathy Whitney
October 2, 2014

Campaign seeks to bolster biosafety practices

Recent lapses in the handling of highly toxic and pathogenic materials at several federal laboratories have prompted the National Institutes of Health (NIH) to announce a new biosafety stewardship initiative.

By VUMC News and Communications
October 2, 2014

Photo: Strong Support

Numerous Emergency Medicine residents, physicians and staff shaved their heads in support of second-year EM resident Ryan Fritz, M.D., MBA, who is currently undergoing chemotherapy for testicular cancer. Fritz was diagnosed earlier this year and underwent surgery, but routine testing later revealed the cancer had spread, thus warranting further treatment.
By VUMC News and Communications
October 2, 2014

American Board of Urology honors VU’s Dmochowski

Roger Dmochowski, M.D., MMHC, professor of Urology and of Obstetrics and Gynecology at Vanderbilt, has been elected a trustee to the American Board of Urology for a six-year term.
By VUMC News and Communications
October 2, 2014

Trivedi to serve on AHA psychiatry council

Harsh Trivedi, M.D., MBA, associate professor of Psychiatry, vice chair for Clinical Affairs for Vanderbilt’s Department of Psychiatry, and executive director and chief medical officer of Vanderbilt Behavioral Health, has been selected to serve on the American Hospital Association’s Governing Council on Psychiatric and Substance Abuse Services.
By Nancy Humphrey
October 2, 2014

Dietetics academy lauds Facemire’s accomplishments

Cynthia Facemire, MMCH, R.D., LDN, administrative director of Vanderbilt University Hospital Expansion and Transition, has been named to receive the Medallion Award from the Academy of Nutrition and Dietetics at the organization’s upcoming Food & Nutrition Conference & Expo in Atlanta.
By VUMC News and Communications
October 2, 2014

Photo: Ethics exploration

Bernard Lo, M.D., director emeritus of the Program in Medical Ethics at the University of California, San Francisco, spoke on issues surrounding end-of-life decisions at his recent Flexner Discovery Lecture.
By VUMC News and Communications
October 2, 2014

Exhibit explores link between “Potter” magic and medicine

A traveling exhibit, “Harry Potter’s World: Renaissance Science, Magic, and Medicine,” debuted this week in the History of Medicine Room at the Annette and Irwin Eskind Biomedical Library at Vanderbilt University Medical Center.
By Wayne Wood
October 2, 2014

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.
By Bill Snyder
1 2